Home Your basket
• Genotype – phenotype corr...
   Price 8.50 €
• Thyroid oncocytomas....
   Price 10.50 €
• Unilateral laryngeal para...
   Price 10.50 €
• Osteointegrated cranio-fa...
   Price 10.50 €
• Orbital apex syndrome fol...
   Price 10.50 €
• The Voice Handicap Index:...
   Price 10.50 €
• Bronchogenic cyst of the ...
   Price 10.50 €
• Aesthetic parotidectomy: ...
   Price 8.50 €
• Fungal sinusitis: Report ...
   Price 10.50 €
• Temporary loss of visual ...
   Price 8.50 €
• A report of two cases of ...
   Price 5.50 €
• Dehiscence of the anterio...
   Price 8.50 €
• How to manage post staped...
   Price 5.50 €
• Aberrant internal carotid...
   Price 5.50 €
• Lifting of the oval face ...
   Price 10.50 €
• Quality of life after rad...
   Price 10.50 €
• Botulinum toxin, descript...
   Price 12.50 €
• Hearing aid : practical a...
   Price 8.50 €
• Which face lift for which...
   Price 14.00 €
• Acceptability of topical ...
   Price 5.50 €
• Cleft palate and otitis m...
   Price 10.50 €
• The EXIT procedure: Princ...
   Price 8.50 €
• The verrucous laryngeal c...
   Price 5.50 €
• Chyle leak after cervical...
   Price 15.00 €
• BAHA in single sided deaf...
   Price 12.50 €
• A study of peristomal rec...
   Price 5.50 €
• Bone-Anchored Hearing Aid...
   Price 10.50 €
• The ENT in operations … T...
   Price 5.50 €
• Bilateral latero-pontine ...
   Price 5.50 €
• Stingy speakers....
   Price 5.50 €
• Vocal fold structure and ...
   Price 10.50 €
• Facial threads for face l...
   Price 10.50 €
• Principes underlying the ...
   Price 10.50 €

Total Order 301.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 2 - 2003 o

CERVICO-FACIAL SURGERY

Interest of the cervical gland dissection after radiotherapy with or without chemotherapy.


Authors : Th. Houliat, D. N'Guyen, L. Eimer, B. Baltazart, C. Convert, K. Diallo, J. Meynard, L. Traissac (Bordeaux)

Ref. : Rev Laryngol Otol Rhinol. 2003;124,2:127-134.

Article published in french
Downloadable PDF document french



Summary : Objectives: The aim of this study was to evaluate the necessity and morbidity of neck dissection after radiation therapy within organ preservation treatment. Patients and methods: We present a retrospective study of 64 patients, treated initially by radiotherapy with or without chemotherapy for squamous cell carcinoma of head and neck with cervical metastases (> 2cm), who underwent post-radiation neck dissection between January 1992 and August 2000. Eight (13%) patients were classified T1, nineteen (30%) T2, twenty (31%) T3, eleven (17%) T4 and six (9%) Tx. Eleven patients had N1 neck disease (17%), fifteen patients N2a (24 %), eleven patients N2b (17%) and twenty-seven patients N3 (42%). Results: Follow-up ranged from 3 to 86 months with a mean of 39 months. The average length of time between neck dissection and the end of treatment was 60 days. Complications were recorded in 21 patients (33%). Forty-four (68%) of 64 patients had microscopic residual disease. Eight (72%) of 11 patients with N1 neck disease and 17 (63%) of 27 patients with N3 neck disease had pathology. Initial N status was not a predictive factor of microscopic residual disease (p=0.51). There was no significant relationship between clinical residual adenopathy and microscopic residual disease (p=0.53). Fourteen patients are still alive without recurrent disease. Eight (57%) of these 14 patients had a positive pathology at the time of neck dissection. The mean follow-up time of these patients is 32.6 months, with a follow up longer than 2 years for half of them (n=7). Conclusion: Neck dissection after radiation was planned for all patients with an initial node > 2 cm in diameter regardless of clinical response in the neck. We confirm that neck dissection appears to be safe after radiotherapy and is necessary because it improves quality of life and prevents fatal evolution with uncontrollable neck disease.

Price : 10.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE